AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2020
Feb 11, 2020
30237_dirs_2020-02-11_d6e78808-00b7-4e6a-916e-bbbe8726a680.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-07
Reporting Person: KING DAVID P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-07 | Common Stock | M | 4220 | — | Acquired | 310175.1345 | Direct |
| 2020-02-07 | Common Stock | F | 1252 | $182.33 | Disposed | 308923.1345 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-07 | Restricted Stock Unit | $ | M | 4220 | Disposed | Common Stock (4220) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 19542 | Indirect |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Amount includes 21.7403 shares acquired on December 31, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3: Stock withholding to satisfy tax withholding obligations.
F4: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2018 and are now fully vested.
F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.